All In Biotech

Drug Trial Radar · NCT02387359

The Plecanatide Irritable Bowel Syndrome With Constipation Safety and Efficacy Study (IBS-C)

A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,054 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,054

Actual

Start

Dec 2014

Primary completion

Dec 2016

Study completion Feb 2017

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
Mar 13, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study in patients with IBS-C is a randomized, double-blind, placebo-controlled, parallel-group clinical trial with 12 weeks of study drug therapy.

Conditions

  • Irritable Bowel Syndrome Characterized by Constipation

Interventions

  • PlecanatideDrug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Overall Responders - ITT PopulationTime frame: 12 Weeks
  2. Number of Abdominal Pain Responders for at Least 6 of 12 Treatment WeeksTime frame: 12 Weeks
  3. Number of Stool Frequency Responder for at Least 6 of the 12 Treatment WeeksTime frame: 12 weeks

Locations

155 sites in 1 country. Site status is shown where the registry gives one.

  • Synergy Research Site

    Athens, Alabama

  • Synergy Research Site

    Birmingham, Alabama

  • Synergy Research Site

    Dothan, Alabama

  • Synergy Research Site

    Foley, Alabama

  • Synergy Research Site

    Huntsville, Alabama

  • Synergy Research Site

    Montgomery, Alabama

  • Synergy Research Site

    Chandler, Arizona

  • Synergy Research Site

    Glendale, Arizona

  • Synergy Research Site

    Phoenix, Arizona

  • Synergy Research Site

    Tucson, Arizona

  • Synergy Research Site

    Tucson, Arizona

  • Synergy Research Site

    Conway, Arkansas

  • Synergy Research Site

    Little Rock, Arkansas

  • Synergy Research Site

    Little Rock, Arkansas

  • Synergy Research Site

    Anaheim, California

  • Synergy Research Site

    Artesia, California

  • Synergy Research Site

    Chula Vista, California

  • Synergy Research Site

    Corona, California

  • Synergy Research Site

    Encino, California

  • Synergy Research Site

    Fountain Valley, California

  • Synergy Research Site

    Fresno, California

  • Synergy Research Site

    Garden Grove, California

  • Synergy Research Site

    La Mesa, California

  • Synergy Research Site

    La Mirada, California

  • Synergy Research Site

    Laguna Hills, California

  • Synergy Research Site

    Lancaster, California

  • Synergy Research Site

    North Hollywood, California

  • Synergy Research Site

    Sacramento, California

  • Synergy Research Site

    San Bernardino, California

  • Synergy Research Site

    San Diego, California

  • Synergy Research Site

    Thousand Oaks, California

  • Synergy Research Site

    Upland, California

  • Synergy Research Site

    Upland, California

  • Synergy Research Site

    Broomfield, Colorado

  • Synergy Research Site.

    Yosemite Centennial, Colorado

  • Synergy Research Site

    Bristol, Connecticut

  • Synergy Research Site

    Hamden, Connecticut

  • Synergy Research Site

    Boynton Beach, Florida

  • Synergy Research Site

    Bradon, Florida

  • Synergy Research Site

    DeLand, Florida

Showing 40 of 155 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.